Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Targeted Oncology|February 2, 2013
Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitroMiklos Jaszberenyi, Andrew V Schally, Norman L Block, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinasesFerenc G Rick, Andrew V Schally, Luca Szalontay, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 functionLuca Szalontay, Andrew V Schally, Petra Popovics, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2014
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonistsMiklos Jaszberenyi, Ferenc G Rick, Petra Popovics, et al.
Cancer Letters|February 17, 2010
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cellsFlorian Hohla, Stefan Buchholz, Andrew V Schally, et al.
Hormones & Cancer|March 11, 2015
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2Paola Catanuto, Jun Tashiro, Ferenc G Rick, et al.
Anti-Cancer Drugs|October 20, 2012
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]Stephan Seitz, Stefan Buchholz, Andrew V Schally, et al.
British Journal of Haematology|April 18, 2018
A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormoneJoaquin J Jimenez, Gina M DelCanto, Petra Popovics, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancersFerenc G Rick, Stefan Buchholz, Andrew V Schally, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelFlorian Hohla, Andrew V Schally, Karoly Szepeshazi, et al.
Pageof 6